Denali Therapeutics Inc (DNLI)
EBITDA Margin
-13823.72%
TTM · Period ending:
DNLI EBITDA Margin
Latest reported-13823.72%period ending
Latest reported-13823.72%period ending
DNLI EBITDA Margin (0.00% → -13823.72%)
Annual ebitda margin
High-resolution chart · PNG
DNLI ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| 0% | |
| -38.8672% | |
| -290.9628% | |
| -580.6765% | |
| 21.2266% | |
| -769.1469% | |
| -30.1618% | |
| 0% | |
| 0% | |
| 0% |